<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>docetaxel</title><link>http://www.unboundmedicine.com/medline/ebm/research/docetaxel</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885749/full_citation/Neoadjuvant_chemotherapy_with_a_combination_of_docetaxel_cisplatin_fluorouracil_and_leucovorin_in_nonresectable_advanced_gastric_cancer:_a_short_communication_</link><description>Ma Y, Qin H, Zheng Q, et al. <br/><span class="title">Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication. [JOURNAL ARTICLE]</span><br/><span class="source" title="Medical oncology (Northwood, London, England)">Med Oncol 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885749/abstract/Neoadjuvant_chemotherapy_with_a_combination_of_docetaxel_cisplatin_fluorouracil_and_leucovorin_in_nonresectable_advanced_gastric_cancer:_a_short_communication_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885749/full_citation/Neoadjuvant_chemotherapy_with_a_combination_of_docetaxel_cisplatin_fluorouracil_and_leucovorin_in_nonresectable_advanced_gastric_cancer:_a_short_communication_">Full Citation</a></description></item><item><title>EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884861/full_citation/EGFR_Mutations_Detected_in_Plasma_Are_Associated_with_Patient_Outcomes_in_Erlotinib_Plus_Docetaxel_Treated_Non_small_Cell_Lung_Cancer_</link><description>Mack PC, Holland WS, Burich RA, et al. <br/><span class="title">EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer">J Thorac Oncol 2009 Oct 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884861/abstract/EGFR_Mutations_Detected_in_Plasma_Are_Associated_with_Patient_Outcomes_in_Erlotinib_Plus_Docetaxel_Treated_Non_small_Cell_Lung_Cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884861/full_citation/EGFR_Mutations_Detected_in_Plasma_Are_Associated_with_Patient_Outcomes_in_Erlotinib_Plus_Docetaxel_Treated_Non_small_Cell_Lung_Cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884861/EGFR_Mutations_Detected_in_Plasma_Are_Associated_with_Patient_Outcomes_in_Erlotinib_Plus_Docetaxel_Treated_Non_small_Cell_Lung_Cancer_">Find Related Articles</a> </description></item><item><title>Phase I Trial of Intrapleural Docetaxel Administered Through an Implantable Catheter in Subjects with a Malignant Pleural Effusion.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884858/full_citation/Phase_I_Trial_of_Intrapleural_Docetaxel_Administered_Through_an_Implantable_Catheter_in_Subjects_with_a_Malignant_Pleural_Effusion_</link><description>Jones DR, Taylor MD, Petroni GR, et al. <br/><span class="title">Phase I Trial of Intrapleural Docetaxel Administered Through an Implantable Catheter in Subjects with a Malignant Pleural Effusion. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer">J Thorac Oncol 2009 Oct 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884858/abstract/Phase_I_Trial_of_Intrapleural_Docetaxel_Administered_Through_an_Implantable_Catheter_in_Subjects_with_a_Malignant_Pleural_Effusion_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884858/full_citation/Phase_I_Trial_of_Intrapleural_Docetaxel_Administered_Through_an_Implantable_Catheter_in_Subjects_with_a_Malignant_Pleural_Effusion_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884858/Phase_I_Trial_of_Intrapleural_Docetaxel_Administered_Through_an_Implantable_Catheter_in_Subjects_with_a_Malignant_Pleural_Effusion_">Find Related Articles</a> </description></item><item><title>Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884557/full_citation/Fluorouracil_Epirubicin_and_Cyclophosphamide_With_Either_Docetaxel_or_Vinorelbine_With_or_Without_Trastuzumab_As_Adjuvant_Treatments_of_Breast_Cancer:_Final_Results_of_the_FinHer_Trial_</link><description>Joensuu H, Bono P, Kataja V, et al. <br/><span class="title">Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884557/abstract/Fluorouracil_Epirubicin_and_Cyclophosphamide_With_Either_Docetaxel_or_Vinorelbine_With_or_Without_Trastuzumab_As_Adjuvant_Treatments_of_Breast_Cancer:_Final_Results_of_the_FinHer_Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884557/full_citation/Fluorouracil_Epirubicin_and_Cyclophosphamide_With_Either_Docetaxel_or_Vinorelbine_With_or_Without_Trastuzumab_As_Adjuvant_Treatments_of_Breast_Cancer:_Final_Results_of_the_FinHer_Trial_">Full Citation</a> | <a href="http://www.jco.org/cgi/pmidlookup%3fview=long%26amp;pmid=19884557">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884557/Fluorouracil_Epirubicin_and_Cyclophosphamide_With_Either_Docetaxel_or_Vinorelbine_With_or_Without_Trastuzumab_As_Adjuvant_Treatments_of_Breast_Cancer:_Final_Results_of_the_FinHer_Trial_">Find Related Articles</a> </description></item><item><title>Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19882157/full_citation/Phase_I/II_study_on_docetaxel_gemcitabine_and_prednisone_in_castrate_refractory_metastatic_prostate_cancer_</link><description>Buch-Hansen TZ, Bentzen L, Hansen S, et al. <br/><span class="title">Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer chemotherapy and pharmacology">Cancer Chemother Pharmacol 2009 Oct 31.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19882157/abstract/Phase_I/II_study_on_docetaxel_gemcitabine_and_prednisone_in_castrate_refractory_metastatic_prostate_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19882157/full_citation/Phase_I/II_study_on_docetaxel_gemcitabine_and_prednisone_in_castrate_refractory_metastatic_prostate_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19882157/Phase_I/II_study_on_docetaxel_gemcitabine_and_prednisone_in_castrate_refractory_metastatic_prostate_cancer_">Find Related Articles</a> </description></item><item><title>Successful treatment of syncope with chemotherapy irresponsive to cardiac pacemaker in head and neck cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19881981/full_citation/Successful_treatment_of_syncope_with_chemotherapy_irresponsive_to_cardiac_pacemaker_in_head_and_neck_cancer_</link><description>Ju JH, Kang MH, Kim HG, et al. <br/><span class="title">Successful treatment of syncope with chemotherapy irresponsive to cardiac pacemaker in head and neck cancer. [Journal Article]</span><br/><span class="source" title="Yonsei medical journal">Yonsei Med J 2009 Oct 31; 50(5):725-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19881981/abstract/Successful_treatment_of_syncope_with_chemotherapy_irresponsive_to_cardiac_pacemaker_in_head_and_neck_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19881981/full_citation/Successful_treatment_of_syncope_with_chemotherapy_irresponsive_to_cardiac_pacemaker_in_head_and_neck_cancer_">Full Citation</a></description></item><item><title>Clusterin and chemoresistance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19879424/full_citation/Clusterin_and_chemoresistance_</link><description>Djeu JY, Wei S <br/><span class="title">Clusterin and chemoresistance. [Journal Article]</span><br/><span class="source" title="Advances in cancer research">Adv Cancer Res 2009.:77-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19879424/abstract/Clusterin_and_chemoresistance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19879424/full_citation/Clusterin_and_chemoresistance_">Full Citation</a></description></item><item><title>The Neuroprotective Effect of Erythropoietin in Docetaxel-Induced Peripheral Neuropathy Causes No Reduction of Antitumor Activity in 13762 Adenocarcinoma-Bearing Rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19876698/full_citation/The_Neuroprotective_Effect_of_Erythropoietin_in_Docetaxel_Induced_Peripheral_Neuropathy_Causes_No_Reduction_of_Antitumor_Activity_in_13762_Adenocarcinoma_Bearing_Rats_</link><description>Cervellini I, Bello E, Frapolli R, et al. <br/><span class="title">The Neuroprotective Effect of Erythropoietin in Docetaxel-Induced Peripheral Neuropathy Causes No Reduction of Antitumor Activity in 13762 Adenocarcinoma-Bearing Rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neurotoxicity research">Neurotox Res 2009 Oct 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19876698/abstract/The_Neuroprotective_Effect_of_Erythropoietin_in_Docetaxel_Induced_Peripheral_Neuropathy_Causes_No_Reduction_of_Antitumor_Activity_in_13762_Adenocarcinoma_Bearing_Rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19876698/full_citation/The_Neuroprotective_Effect_of_Erythropoietin_in_Docetaxel_Induced_Peripheral_Neuropathy_Causes_No_Reduction_of_Antitumor_Activity_in_13762_Adenocarcinoma_Bearing_Rats_">Full Citation</a></description></item><item><title>The Herb Medicine Formula 'Chong Lou Fu Fang' Increases the Cytotoxicity of Chemotherapeutic Agents and Down-regulates the Expression of Chemotherapeutic Agent Resistance-related Genes in Human Gastric Cancer Cells In Vitro.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875432/full_citation/The_Herb_Medicine_Formula_'Chong_Lou_Fu_Fang'_Increases_the_Cytotoxicity_of_Chemotherapeutic_Agents_and_Down_regulates_the_Expression_of_Chemotherapeutic_Agent_Resistance_related_Genes_in_Human_Gastric_Cancer_Cells_In_Vitro_</link><description>Liu Y, Ling Y, Hu W, et al. <br/><span class="title">The Herb Medicine Formula 'Chong Lou Fu Fang' Increases the Cytotoxicity of Chemotherapeutic Agents and Down-regulates the Expression of Chemotherapeutic Agent Resistance-related Genes in Human Gastric Cancer Cells In Vitro. [JOURNAL ARTICLE]</span><br/><span class="source" title="Evidence-based complementary and alternative medicine : eCAM">Evid Based Complement Alternat Med 2009 Oct 29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875432/abstract/The_Herb_Medicine_Formula_'Chong_Lou_Fu_Fang'_Increases_the_Cytotoxicity_of_Chemotherapeutic_Agents_and_Down_regulates_the_Expression_of_Chemotherapeutic_Agent_Resistance_related_Genes_in_Human_Gastric_Cancer_Cells_In_Vitro_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19875432/full_citation/The_Herb_Medicine_Formula_'Chong_Lou_Fu_Fang'_Increases_the_Cytotoxicity_of_Chemotherapeutic_Agents_and_Down_regulates_the_Expression_of_Chemotherapeutic_Agent_Resistance_related_Genes_in_Human_Gastric_Cancer_Cells_In_Vitro_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19875432/The_Herb_Medicine_Formula_'Chong_Lou_Fu_Fang'_Increases_the_Cytotoxicity_of_Chemotherapeutic_Agents_and_Down_regulates_the_Expression_of_Chemotherapeutic_Agent_Resistance_related_Genes_in_Human_Gastric_Cancer_Cells_In_Vitro_">Find Related Articles</a> </description></item><item><title>CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19866475/full_citation/CCL2_is_induced_by_chemotherapy_and_protects_prostate_cancer_cells_from_docetaxel_induced_cytotoxicity_</link><description>Qian DZ, Rademacher BL, Pittsenbarger J, et al. <br/><span class="title">CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Prostate">Prostate 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19866475/abstract/CCL2_is_induced_by_chemotherapy_and_protects_prostate_cancer_cells_from_docetaxel_induced_cytotoxicity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19866475/full_citation/CCL2_is_induced_by_chemotherapy_and_protects_prostate_cancer_cells_from_docetaxel_induced_cytotoxicity_">Full Citation</a></description></item></channel></rss>